FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PLoS One / Effects of administration of live or inactivated virulent Rh...
PloS one2013; 8(6); e66640; doi: 10.1371/journal.pone.0066640

Effects of administration of live or inactivated virulent Rhodococccus equi and age on the fecal microbiome of neonatal foals.

Abstract: Rhodococcus equi is an important pathogen of foals. Enteral administration of live, virulent R. equi during early life has been documented to protect against subsequent intrabronchial challenge with R. equi, indicating that enteral mucosal immunization may be protective. Evidence exists that mucosal immune responses develop against both live and inactivated micro-organisms. The extent to which live or inactivated R. equi might alter the intestinal microbiome of foals is unknown. This is an important question because the intestinal microbiome of neonates of other species is known to change over time and to influence host development. To our knowledge, changes in the intestinal microbiome of foals during early life have not been reported. Thus, the purpose of this study was to determine whether age (during the first month of life) or administration of either live virulent R. equi (at a dose reported to protect foals against subsequent intrabronchial challenge, viz., 1×10(10) colony forming units [CFU]) or inactivated virulent R. equi (at higher doses, viz., 2×10(10) and 1×10(11) [CFU]) altered the fecal microbiome of foals. Results: Fecal swab samples from 42 healthy foals after vaccination with low-dose inactivated R. equi (n = 9), high-dose inactivated R. equi (n = 10), live R. equi (n = 6), control with cholera toxin B (CTB, n = 9), and control without CTB (n = 8) were evaluated by 454-pyrosequencing of the 16S rRNA gene and by qPCR. No impact of treatment was observed among vaccinated foals; however, marked and significant differences in microbial communities and diversity were observed between foals at 30 days of age relative to 2 days of age. Conclusions: The results suggest age-related changes in the fecal microbial population of healthy foals do occur, however, mucosal vaccination does not result in major changes of the fecal microbiome in foals.
Get Full Text
Publication Date: 2013-06-13 PubMed ID: 23785508PubMed Central: PMC3681940DOI: 10.1371/journal.pone.0066640Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This article investigates the impact of administering virulent Rhodococcus equi, either live or inactivated, and the age of the neonatal foals on their fecal microbiome. The study found significant age-related changes in the microbial communities and diversity in the feces of foals but observed no major alterations due to mucosal vaccination.

Introduction and Study Purpose

  • This scientific article deals with the study of the potential effect of administration of live or inactivated bacteria, specifically Rhodococcus equi, on the composition of the intestinal microbiome of neonatal foals (baby horses). Rhodococcus equi is a pathogenic bacterium known to affect foals.
  • The study aimed to fill the knowledge gap about how this bacterium, whether in inactive or live form, might change the intestinal microbiome of these young animals. The intestinal microbiome has been shown to change over time in animals and to play a significant role in the development of the host.
  • Further, the study set out to determine the effect of foals’ age on the fecal microbiome in the first month of life. This is because the intestinal microbiome of foals during early life has not been previously studied.

Methodology

  • The team completed their research by using a controlled sample of 42 healthy foals. This sample was split to apply variations of treatment, which included both doses of inactivated R. equi at different levels, live R. equi, control with cholera toxin B (CTB), and control without CTB.
  • The results were gathered by performing 454-pyrosequencing of the 16S rRNA gene and qPCR on fecal swab samples from the foals. This allowed the research team to observe any potential variations in the fecal microbiome as a result of the treatments.

Results and Conclusion

  • The observed results of the study showed no significant effects of the treatment on the fecal microbiome of the foals. That is, neither the live nor the inactivated R. equi caused any noticeable changes to the composition of the intestinal microbiome of the subjects.
  • However, the research found that there were considerable and statistically significant differences in the foals’ microbial communities and diversity at the age of 30 days compared to at 2 days. This suggests that alterations in the fecal microbiome do take place as a foal ages, even though the administration of the mucosal vaccine does not have a noticeable effect.
  • In conclusion, although mucosal vaccination did not significantly alter foals’ fecal microbiome, age did make a difference. This potentially points to the importance of studying the influence of age on the foal’s microbiome as they grow.

Cite This Article

APA
Bordin AI, Suchodolski JS, Markel ME, Weaver KB, Steiner JM, Dowd SE, Pillai S, Cohen ND. (2013). Effects of administration of live or inactivated virulent Rhodococccus equi and age on the fecal microbiome of neonatal foals. PLoS One, 8(6), e66640. https://doi.org/10.1371/journal.pone.0066640

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 8
Issue: 6
Pages: e66640
PII: e66640

Researcher Affiliations

Bordin, Angela I
  • Equine Infectious Diseases Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Suchodolski, Jan S
    Markel, Melissa E
      Weaver, Kaytee B
        Steiner, Jörg M
          Dowd, Scot E
            Pillai, Suresh
              Cohen, Noah D

                MeSH Terms

                • Age Factors
                • Animals
                • Animals, Newborn
                • Bacterial Vaccines / administration & dosage
                • Bacterial Vaccines / immunology
                • Feces / chemistry
                • Feces / microbiology
                • Horses
                • Microbiota / genetics
                • Molecular Typing
                • RNA, Ribosomal, 16S
                • Rhodococcus equi / immunology
                • Rhodococcus equi / pathogenicity
                • Sequence Analysis, DNA
                • Vaccines, Inactivated
                • Vaccines, Live, Unattenuated

                Conflict of Interest Statement

                The authors declare that they had partial support for this work through an unrestricted gift from Boehringer-Ingelheim to our laboratory and a scholarship from Fort Dodge Animal Health/Pfizer Animal Health for Dr. Angela Bordin. This industry funding does not relate to or involve any patents, products in development, marketed products, or any other private or proprietary interests. The authors do not have any consultancy agreements with these companies, and none of this work pertains to products in development or produced by these companies. This funding does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

                References

                This article includes 53 references
                1. Meijer WG, Prescott JF. Rhodococcus equi.. Vet Res 2004 Jul-Aug;35(4):383-96.
                  pubmed: 15236672doi: 10.1051/vetres:2004024google scholar: lookup
                2. Muscatello G, Leadon DP, Klayt M, Ocampo-Sosa A, Lewis DA, Fogarty U, Buckley T, Gilkerson JR, Meijer WG, Vazquez-Boland JA. Rhodococcus equi infection in foals: the science of 'rattles'.. Equine Vet J 2007 Sep;39(5):470-8.
                  pubmed: 17910275doi: 10.2746/042516407x209217google scholar: lookup
                3. Prescott JF. Rhodococcus equi: an animal and human pathogen.. Clin Microbiol Rev 1991 Jan;4(1):20-34.
                  pmc: PMC358176pubmed: 2004346doi: 10.1128/cmr.4.1.20google scholar: lookup
                4. Takai S. Epidemiology of Rhodococcus equi infections: a review.. Vet Microbiol 1997 Jun 16;56(3-4):167-76.
                  pubmed: 9226831doi: 10.1016/s0378-1135(97)00085-0google scholar: lookup
                5. Giguère S, Cohen ND, Chaffin MK, Hines SA, Hondalus MK, Prescott JF, Slovis NM. Rhodococcus equi: clinical manifestations, virulence, and immunity.. J Vet Intern Med 2011 Nov-Dec;25(6):1221-30.
                  pubmed: 22092609doi: 10.1111/j.1939-1676.2011.00804.xgoogle scholar: lookup
                6. Jain S, Bloom BR, Hondalus MK. Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi.. Mol Microbiol 2003 Oct;50(1):115-28.
                  pubmed: 14507368doi: 10.1046/j.1365-2958.2003.03689.xgoogle scholar: lookup
                7. Dawson TRMY, Horohov DW, Meijer WG, Muscatello G. Current understanding of the equine immune response to Rhodococcus equi. An immunological review of R. equi pneumonia.. Vet Immunol Immunopathol 2010 May 15;135(1-2):1-11.
                  pubmed: 20064668doi: 10.1016/j.vetimm.2009.12.004google scholar: lookup
                8. Harris SP, Fujiwara N, Mealey RH, Alperin DC, Naka T, Goda R, Hines SA. Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes.. Microbiology (Reading) 2010 Jun;156(Pt 6):1836-1847.
                  pmc: PMC4086205pubmed: 20299405doi: 10.1099/mic.0.035915-0google scholar: lookup
                9. Patton KM, McGuire TC, Hines MT, Mealey RH, Hines SA. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.. Infect Immun 2005 Apr;73(4):2083-93.
                  pmc: PMC1087435pubmed: 15784549doi: 10.1128/iai.73.4.2083-2093.2005google scholar: lookup
                10. Horowitz ML, Cohen ND, Takai S, Becu T, Chaffin MK, Chu KK, Magdesian KG, Martens RJ. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection.. J Vet Intern Med 2001 May-Jun;15(3):171-5.
                  pubmed: 11380023doi: 10.1892/0891-6640(2001)015<0171:aosmld>2.3.co;2google scholar: lookup
                11. Chaffin MK, Cohen ND, Martens RJ. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections.. J Am Vet Med Assoc 2008 Apr 1;232(7):1035-47.
                  pubmed: 18380623doi: 10.2460/javma.232.7.1035google scholar: lookup
                12. Chirino-Trejo JM, Prescott JF, Yager JA. Protection of foals against experimental Rhodococcus equi pneumonia by oral immunization.. Can J Vet Res 1987 Oct;51(4):444-7.
                  pmc: PMC1255362pubmed: 3453264
                13. Hooper-McGrevy KE, Wilkie BN, Prescott JF. Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi.. Vaccine 2005 Dec 30;23(50):5760-7.
                  pubmed: 16112256doi: 10.1016/j.vaccine.2005.07.050google scholar: lookup
                14. van der Geize R, Grommen AW, Hessels GI, Jacobs AA, Dijkhuizen L. The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development.. PLoS Pathog 2011 Aug;7(8):e1002181.
                  pmc: PMC3161971pubmed: 21901092doi: 10.1371/journal.ppat.1002181google scholar: lookup
                15. Arnold H, Bumann D, Felies M, Gewecke B, Sörensen M, Gessner JE, Freihorst J, von Specht BU, Baumann U. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.. Infect Immun 2004 Nov;72(11):6546-53.
                  pmc: PMC523058pubmed: 15501786doi: 10.1128/iai.72.11.6546-6553.2004google scholar: lookup
                16. Villena J, Medina M, Raya R, Alvarez S. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.. Can J Microbiol 2008 Oct;54(10):845-53.
                  pubmed: 18923553doi: 10.1139/w08-077google scholar: lookup
                17. KuoLee R, Harris G, Conlan JW, Chen W. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.. Vaccine 2007 May 10;25(19):3781-91.
                  pmc: PMC1931493pubmed: 17346863doi: 10.1016/j.vaccine.2007.02.014google scholar: lookup
                18. Clark SO, Kelly DL, Badell E, Castello-Branco LR, Aldwell F, Winter N, Lewis DJ, Marsh PD. Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination.. Vaccine 2010 Oct 8;28(43):7109-16.
                  pubmed: 20708695doi: 10.1016/j.vaccine.2010.07.087google scholar: lookup
                19. Tompkins DM, Buddle BM, Whitford J, Cross ML, Yates GF, Lambeth MR, Nugent G. Sustained protection against tuberculosis conferred to a wildlife host by single dose oral vaccination.. Vaccine 2013 Jan 30;31(6):893-9.
                  pubmed: 23246543doi: 10.1016/j.vaccine.2012.12.003google scholar: lookup
                20. Ancelet LR, Aldwell FE, Rich FJ, Kirman JR. Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune response.. PLoS One 2012;7(9):e45888.
                  pmc: PMC3457949pubmed: 23049885doi: 10.1371/journal.pone.0045888google scholar: lookup
                21. Garrido JM, Sevilla IA, Beltrán-Beck B, Minguijón E, Ballesteros C, Galindo RC, Boadella M, Lyashchenko KP, Romero B, Geijo MV, Ruiz-Fons F, Aranaz A, Juste RA, Vicente J, de la Fuente J, Gortázar C. Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis.. PLoS One 2011;6(9):e24905.
                  pmc: PMC3173485pubmed: 21935486doi: 10.1371/journal.pone.0024905google scholar: lookup
                22. Quan FS, Compans RW, Kang SM. Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.. Vaccine 2012 Jan 5;30(2):180-8.
                  pmc: PMC5555299pubmed: 22107852doi: 10.1016/j.vaccine.2011.11.028google scholar: lookup
                23. Sealy R, Webby RJ, Crumpton JC, Hurwitz JL. Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines.. Int Immunol 2013 Mar;25(3):183-95.
                  pmc: PMC3579181pubmed: 23143476doi: 10.1093/intimm/dxs107google scholar: lookup
                24. Paillot R, Prowse L, Montesso F, Huang CM, Barnes H, Escala J. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.. Vet Microbiol 2013 Mar 23;162(2-4):396-407.
                  pubmed: 23146168doi: 10.1016/j.vetmic.2012.10.019google scholar: lookup
                25. Mshvildadze M, Neu J. The infant intestinal microbiome: friend or foe?. Early Hum Dev 2010 Jul;86 Suppl 1(Suppl 1):67-71.
                  pmc: PMC3586601pubmed: 20116944doi: 10.1016/j.earlhumdev.2010.01.018google scholar: lookup
                26. Murgas Torrazza R, Neu J. The developing intestinal microbiome and its relationship to health and disease in the neonate.. J Perinatol 2011 Apr;31 Suppl 1:S29-34.
                  pubmed: 21448201doi: 10.1038/jp.2010.172google scholar: lookup
                27. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota.. PLoS Biol 2007 Jul;5(7):e177.
                  pmc: PMC1896187pubmed: 17594176doi: 10.1371/journal.pbio.0050177google scholar: lookup
                28. Inman CF, Laycock GM, Mitchard L, Harley R, Warwick J, Burt R, van Diemen PM, Stevens M, Bailey M. Neonatal colonisation expands a specific intestinal antigen-presenting cell subset prior to CD4 T-cell expansion, without altering T-cell repertoire.. PLoS One 2012;7(3):e33707.
                  pmc: PMC3307746pubmed: 22442714doi: 10.1371/journal.pone.0033707google scholar: lookup
                29. Willing BP, Van Kessel AG. Enterocyte proliferation and apoptosis in the caudal small intestine is influenced by the composition of colonizing commensal bacteria in the neonatal gnotobiotic pig.. J Anim Sci 2007 Dec;85(12):3256-66.
                  pubmed: 17785595doi: 10.2527/jas.2007-0320google scholar: lookup
                30. Halbert ND, Reitzel RA, Martens RJ, Cohen ND. Evaluation of a multiplex polymerase chain reaction assay for simultaneous detection of Rhodococcus equi and the vapA gene.. Am J Vet Res 2005 Aug;66(8):1380-5.
                  pubmed: 16173481doi: 10.2460/ajvr.2005.66.1380google scholar: lookup
                31. Mashoof S, Goodroe A, Du CC, Eubanks JO, Jacobs N, Steiner JM, Tizard I, Suchodolski JS, Criscitiello MF. Ancient T-independence of mucosal IgX/A: gut microbiota unaffected by larval thymectomy in Xenopus laevis.. Mucosal Immunol 2013 Mar;6(2):358-68.
                  pmc: PMC3514589pubmed: 22929561doi: 10.1038/mi.2012.78google scholar: lookup
                32. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation.. Genome Biol 2011 Jun 24;12(6):R60.
                  pmc: PMC3218848pubmed: 21702898doi: 10.1186/gb-2011-12-6-r60google scholar: lookup
                33. Garcia-Mazcorro JF, Dowd SE, Poulsen J, Steiner JM, Suchodolski JS. Abundance and short-term temporal variability of fecal microbiota in healthy dogs.. Microbiologyopen 2012 Sep;1(3):340-7.
                  pmc: PMC3496977pubmed: 23170232doi: 10.1002/mbo3.36google scholar: lookup
                34. Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, Kachroo P, Ivanov I, Minamoto Y, Dillman EM, Steiner JM, Cook AK, Toresson L. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease.. PLoS One 2012;7(12):e51907.
                  pmc: PMC3530590pubmed: 23300577doi: 10.1371/journal.pone.0051907google scholar: lookup
                35. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75: 800–802.
                36. Shannon CE, Weaver W. The mathematical theory of communication. Urbana, IL: University of Illinois Press.
                37. Chao A. Estimating the population size for capture-recapture data with unequal catchability.. Biometrics 1987 Dec;43(4):783-91.
                  pubmed: 3427163
                38. Garcia-Mazcorro JF, Lanerie DJ, Dowd SE, Paddock CG, Grützner N, Steiner JM, Ivanek R, Suchodolski JS. Effect of a multi-species synbiotic formulation on fecal bacterial microbiota of healthy cats and dogs as evaluated by pyrosequencing.. FEMS Microbiol Ecol 2011 Dec;78(3):542-54.
                  pubmed: 22067056doi: 10.1111/j.1574-6941.2011.01185.xgoogle scholar: lookup
                39. Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.. Aliment Pharmacol Ther 1999 Aug;13(8):1103-8.
                  pubmed: 10468688doi: 10.1046/j.1365-2036.1999.00560.xgoogle scholar: lookup
                40. Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME, Brigidi P. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles.. BMC Microbiol 2010 Jan 7;10:4.
                  pmc: PMC2806344pubmed: 20055983doi: 10.1186/1471-2180-10-4google scholar: lookup
                41. Jia J, Frantz N, Khoo C, Gibson GR, Rastall RA, McCartney AL. Investigation of the faecal microbiota of kittens: monitoring bacterial succession and effect of diet.. FEMS Microbiol Ecol 2011 Nov;78(2):395-404.
                  pubmed: 22092177doi: 10.1111/j.1574-6941.2011.01172.xgoogle scholar: lookup
                42. Minamoto Y, Hooda S, Swanson KS, Suchodolski JS. Feline gastrointestinal microbiota.. Anim Health Res Rev 2012 Jun;13(1):64-77.
                  pubmed: 22853923doi: 10.1017/s1466252312000060google scholar: lookup
                43. Buddington RK. Postnatal changes in bacterial populations in the gastrointestinal tract of dogs.. Am J Vet Res 2003 May;64(5):646-51.
                  pubmed: 12755306doi: 10.2460/ajvr.2003.64.646google scholar: lookup
                44. Scholtens PA, Oozeer R, Martin R, Amor KB, Knol J. The early settlers: intestinal microbiology in early life.. Annu Rev Food Sci Technol 2012;3:425-47.
                  pubmed: 22224552doi: 10.1146/annurev-food-022811-101120google scholar: lookup
                45. Shepherd ML, Swecker WS Jr, Jensen RV, Ponder MA. Characterization of the fecal bacteria communities of forage-fed horses by pyrosequencing of 16S rRNA V4 gene amplicons.. FEMS Microbiol Lett 2012 Jan;326(1):62-8.
                  pubmed: 22092776doi: 10.1111/j.1574-6968.2011.02434.xgoogle scholar: lookup
                46. Daly K, Stewart CS, Flint HJ, Shirazi-Beechey SP. Bacterial diversity within the equine large intestine as revealed by molecular analysis of cloned 16S rRNA genes. FEMS Microbiology Ecology 38: 141–151.
                47. Costa M, Sturgeon A, Arroyo LG, Staempfli H, Weese JS. The horse's 2nd genome; metagenomic investigation of the equine intestinal microbiome. 2011; Denver, Colorado.
                48. Suchodolski JS. Companion animals symposium: microbes and gastrointestinal health of dogs and cats.. J Anim Sci 2011 May;89(5):1520-30.
                  pmc: PMC7199667pubmed: 21075970doi: 10.2527/jas.2010-3377google scholar: lookup
                49. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development.. Acta Paediatr Suppl 2003 Sep;91(441):48-55.
                  pubmed: 14599042doi: 10.1111/j.1651-2227.2003.tb00646.xgoogle scholar: lookup
                50. Smith P, MacDonald TT, Blumerg RS. Principles of Mucosal Immunology. New York, NY: Garland Science. 529 p..
                51. Dougal K, Harris PA, Edwards A, Pachebat JA, Blackmore TM, Worgan HJ, Newbold CJ. A comparison of the microbiome and the metabolome of different regions of the equine hindgut.. FEMS Microbiol Ecol 2012 Dec;82(3):642-52.
                  pubmed: 22757649doi: 10.1111/j.1574-6941.2012.01441.xgoogle scholar: lookup
                52. Whitehead AE, Parreira VR, Hewson J, Watson JL, Prescott JF. Development of a live, attenuated, potential vaccine strain of R. equi expressing vapA and the virR operon, and virulence assessment in the mouse.. Vet Immunol Immunopathol 2012 Jan 15;145(1-2):479-84.
                  pubmed: 22088674doi: 10.1016/j.vetimm.2011.10.011google scholar: lookup
                53. Giguère S, Cohen ND, Chaffin MK, Slovis NM, Hondalus MK, Hines SA, Prescott JF. Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals.. J Vet Intern Med 2011 Nov-Dec;25(6):1209-20.
                  pubmed: 22092608doi: 10.1111/j.1939-1676.2011.00835.xgoogle scholar: lookup

                Citations

                This article has been cited 10 times.
                1. Tavenner MK, McDonnell SM, Biddle AS. Development of the equine hindgut microbiome in semi-feral and domestic conventionally-managed foals.. Anim Microbiome 2020 Nov 23;2(1):43.
                  doi: 10.1186/s42523-020-00060-6pubmed: 33499959google scholar: lookup
                2. Kauter A, Epping L, Semmler T, Antao EM, Kannapin D, Stoeckle SD, Gehlen H, Lübke-Becker A, Günther S, Wieler LH, Walther B. The gut microbiome of horses: current research on equine enteral microbiota and future perspectives.. Anim Microbiome 2019 Nov 13;1(1):14.
                  doi: 10.1186/s42523-019-0013-3pubmed: 33499951google scholar: lookup
                3. Mullen KR, Yasuda K, Divers TJ, Weese JS. Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions.. Equine Vet Educ 2018 Mar;30(3):151-160.
                  doi: 10.1111/eve.12559pubmed: 32313396google scholar: lookup
                4. Álvarez-Narváez S, Berghaus LJ, Morris ERA, Willingham-Lane JM, Slovis NM, Giguere S, Cohen ND. A Common Practice of Widespread Antimicrobial Use in Horse Production Promotes Multi-Drug Resistance.. Sci Rep 2020 Jan 22;10(1):911.
                  doi: 10.1038/s41598-020-57479-9pubmed: 31969575google scholar: lookup
                5. Lindenberg F, Krych L, Kot W, Fielden J, Frøkiær H, van Galen G, Nielsen DS, Hansen AK. Development of the equine gut microbiota.. Sci Rep 2019 Oct 8;9(1):14427.
                  doi: 10.1038/s41598-019-50563-9pubmed: 31594971google scholar: lookup
                6. Yang Q, Huang X, Wang P, Yan Z, Sun W, Zhao S, Gun S. Longitudinal development of the gut microbiota in healthy and diarrheic piglets induced by age-related dietary changes.. Microbiologyopen 2019 Dec;8(12):e923.
                  doi: 10.1002/mbo3.923pubmed: 31496126google scholar: lookup
                7. De La Torre U, Henderson JD, Furtado KL, Pedroja M, Elenamarie O, Mora A, Pechanec MY, Maga EA, Mienaltowski MJ. Utilizing the fecal microbiota to understand foal gut transitions from birth to weaning.. PLoS One 2019;14(4):e0216211.
                  doi: 10.1371/journal.pone.0216211pubmed: 31039168google scholar: lookup
                8. Madrigal RG, Shaw SD, Witkowski LA, Sisson BE, Blodgett GP, Chaffin MK, Cohen ND. Use of Serial Quantitative PCR of the vapA Gene of Rhodococcus equi in Feces for Early Detection of R. equi Pneumonia in Foals.. J Vet Intern Med 2016 Mar-Apr;30(2):664-70.
                  doi: 10.1111/jvim.13828pubmed: 26806422google scholar: lookup
                9. Whitfield-Cargile CM, Cohen ND, Suchodolski J, Chaffin MK, McQueen CM, Arnold CE, Dowd SE, Blodgett GP. Composition and Diversity of the Fecal Microbiome and Inferred Fecal Metagenome Does Not Predict Subsequent Pneumonia Caused by Rhodococcus equi in Foals.. PLoS One 2015;10(8):e0136586.
                  doi: 10.1371/journal.pone.0136586pubmed: 26305682google scholar: lookup
                10. Costa MC, Stämpfli HR, Arroyo LG, Allen-Vercoe E, Gomes RG, Weese JS. Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs.. BMC Vet Res 2015 Feb 3;11:19.
                  doi: 10.1186/s12917-015-0335-7pubmed: 25644524google scholar: lookup
                Subscribe to our newsletter
                Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.